Since 1964 The Use Of Benzodiazepines In This Country Has Exploded To Epidemic Proportions. Librium, the first benzodiazepine, soon became known as "mothers little helper" and prescriptions for these "tranquilizers" were soon in the millions per year. People began to expect a pill to solve their problems of worry and anxiety and we soon stopped "solving" our problems and took drugs to change the way we felt.
No one knew or expected that the use of these pharmaceuticals would one day create a monster of a problem linked to their use. As patients took these drugs for longer periods of time and then attempted to stop they were confronted with terrible psychological and physiological withdrawal symptoms which incapacitated them. People in withdrawal have lost jobs, families, their very lives as the extreme anxiety, sleeplessness, confusion, heart problems and other extreme withdrawal factors prevented them from interacting in society in any meaningful manner. Even those patients who attempted to very slowly taper their dosages and gradually withdraw from this dependency experienced some degree of discomfort and the difficulty remained for months and years after use. While they were no longer "dependent" on the benzodiazepine they continued to suffer withdrawal and a significant degree of disability.
Over the years even more potent benzodiazepines have been developed with the result that even more debilitating withdrawal is now evident. Studies have shown that long term use of benzodiazepines results in the reduction of certain normal neurotransmitter availability, mainly those which are associated with the Gamma Amino Butyric Acid, GABA, receptor site. The Gamma Amino Butyric Acid (GABA) receptor is an extremely complex receptor system. GABA accounts for almost 40% of all neurotransmitters in the brain and this fact indicates it's importance in maintaining calm and logical thinking. As the GABA brain site is continuously provided with drugs which mimic the configuration and action of normal neurotransmitters the brain begins to reduce their production in favor of the easily available medication. These drugs, while effective for short-term relief of acute anxiety, produce significant withdrawal difficulties if used for more than the 2 - 4 weeks as recommended by the manufacturers.
Neu-Relieve™ is a special formula consisting of vitamins, minerals and amino acids designed to nutritionally support production of the neurotransmitters that are depleted by the long term use of tranquilizers. In a September, 2002 study, Neu-Relieve was shown to reduce the acute and protracted withdrawal symptoms, which make the recovery process so difficult. Neu-Relieve™ is NOT intended to take the place of benzodiazepines. Benzodiazepines should never be stopped abruptly. This supplement provides nutritional support for natural replenishment of neurotransmitters depleted by the tranquilizers.
Directions: Take 30 minutes or more before meals. Take three capsules two times daily.
Precautions: Should not be used by phenylketonurics. Should not be used by pregnant or lactating women. Persons taking Monoamine Oxidase Inhibitors should only use the product under the supervision of a medical doctor.
Anyone taking medications should consult a doctor before using any product. This product is not intended to take the place of prescription medications.
Each Serving of NeuRelieve Contains:
|Active ingredients per serving||Amount per serving||% Daily Value|
|Vitamin C (Ascorbic Acid)||100mg||166.6|
|Vitamin B6 (Pyridoxal 5 Phosphate)||2mg||100|
|Folic Acid (Folate)||130mcg||32.5|
|5 HTP (5 Hydroxy Tryptophan)||20mg||+|
|No sugar, starch, salt, milk, yeast, preservatives or chemical additives. No artificial dyes, colors or flavors. Gluten free|
|+ Daily value not established Other ingredients: Gelatin, microcrystalline cellulose, silica, vegetable stearate|
|US Patents: 4,7761,429 5,189,064 5,922,361 & 6,159,506|